Martha Goldberg Aronson - May 10, 2021 Form 4 Insider Report for Cardiovascular Systems Inc (CSII)

Role
Director
Signature
/s/ Amanda Lorentz as Attorney-in-Fact for Martha Goldberg Aronson pursuant to Power of Attorney previously filed.
Stock symbol
CSII
Transactions as of
May 10, 2021
Transactions value $
$51,885
Form type
4
Date filed
5/11/2021, 08:04 AM
Next filing
Jun 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSII Common Stock Purchase $51.9K +1.5K +25% $34.59 7.5K May 10, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CSII Restricted Stock Units 12.3K May 10, 2021 Common Stock 12.3K Direct F1
holding CSII Restricted Stock Units 2.41K May 10, 2021 Common Stock 2.41K Direct F2
holding CSII Restricted Stock Units 4.66K May 10, 2021 Common Stock 4.66K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
F2 Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment, and shall be payable in cash or shares of Company common stock on the payment date.
F3 Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,166 shares on September 30, 2020 and 1,165 shares on each of December 31, 2020, March 31, 2021 and June 30, 2021.